Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,296 | Dovepress* | 5,314+ | 735 | 6,049 | |
PubMed Central* | 982 | 249 | 1,231 | ||
Totals | 6,296 | 984 | 7,280 | ||
*Since 25 September 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
29 | 0 | 0 | 0 | 1 | 28 |
View citations on PubMed and Google Scholar